I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl…
marijuana
Cannabis companies are a hard sell to Canadian investors, after years of some of the most irresponsible pubco management making that sector taboo, but there are still good targets…
I built my career on cannabis investing. At one point, a full third of the cannabis public companies in Canada were doing business with me. I spotted the first…
The Cannabis space has been garnering a lot of attention. Maybe not from the mainstream financial media, but definitely from the retail crowd. I cannot even begin to tell…
Is it time to buy Cannabis? Over the recent weeks, here on Equity Guru, I have been telling readers and discord members that the bottom may be in for…
Let’s be honest. 2021 wasn’t a great year for cannabis. We kicked off the year with some excitement and hope that the new Democrat administration would federally legalize cannabis….
Isracann Biosciences (IPOT.C) received a foreign owner cannabis license from the Israeli Minister of Health today, according to a press release. Getting this license concludes Isracann’s regulatory compliance requirements…
In the annals of history, the concept of ‘win/win’ will be looked back on by future folk to be properly defined by today’s news Canopy Growth Corp (WEED.T) is…
Khiron Life Sciences (KHRN.V) has established an offshore inventory of dried cannabis flower with the intent of serving UK patients as well as alleviating bottlenecks and stock outs of…
Investing is a particularly fluid art. This fluidity shows itself in the selection of an appropriate intrinsic value. And it is always best to go back and recheck your…